TY - JOUR
T1 - Cervical cancer, version 3.2019
AU - Koh, Wui Jin
AU - Abu-Rustum, Nadeem R.
AU - Bean, Sarah
AU - Bradley, Kristin
AU - Campos, Susana M.
AU - Cho, Kathleen R.
AU - Chon, Hye Sook
AU - Chu, Christina
AU - Clark, Rachel
AU - Cohn, David
AU - Crispens, Marta Ann
AU - Damast, Shari
AU - Dorigo, Oliver
AU - Eifel, Patricia J.
AU - Fisher, Christine M.
AU - Frederick, Peter
AU - Gaffney, David K.
AU - Han, Ernest
AU - Huh, Warner K.
AU - Lurain, John R.
AU - Mariani, Andrea
AU - Mutch, David
AU - Nagel, Christa
AU - Nekhlyudov, Larissa
AU - Fader, Amanda Nickles
AU - Remmenga, Steven W.
AU - Reynolds, R. Kevin
AU - Tillmanns, Todd
AU - Ueda, Stefanie
AU - Wyse, Emily
AU - Yashar, Catheryn M.
AU - McMillian, Nicole R.
AU - Scavone, Jillian L.
N1 - Publisher Copyright:
© National Comprehensive Cancer Network, Inc. 2019. All rights reserved.
PY - 2019/1
Y1 - 2019/1
N2 - Cervical cancer is a malignant epithelial tumor that forms in the uterine cervix. Most cases of cervical cancer are preventable through human papilloma virus (HPV) vaccination, routine screening, and treatment of precancerous lesions. However, due to inadequate screening protocols in many regions of the world, cervical cancer remains the fourth-most common cancer in women globally. The complete NCCN Guidelines for Cervical Cancer provide recommendations for the diagnosis, evaluation, and treatment of cervical cancer. This manuscript discusses guiding principles for the workup, staging, and treatment of early stage and locally advanced cervical cancer, as well as evidence for these recommendations. For recommendations regarding treatment of recurrent or metastatic disease, please see the full guidelines on NCCN.org.
AB - Cervical cancer is a malignant epithelial tumor that forms in the uterine cervix. Most cases of cervical cancer are preventable through human papilloma virus (HPV) vaccination, routine screening, and treatment of precancerous lesions. However, due to inadequate screening protocols in many regions of the world, cervical cancer remains the fourth-most common cancer in women globally. The complete NCCN Guidelines for Cervical Cancer provide recommendations for the diagnosis, evaluation, and treatment of cervical cancer. This manuscript discusses guiding principles for the workup, staging, and treatment of early stage and locally advanced cervical cancer, as well as evidence for these recommendations. For recommendations regarding treatment of recurrent or metastatic disease, please see the full guidelines on NCCN.org.
UR - http://www.scopus.com/inward/record.url?scp=85060134132&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060134132&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2019.0001
DO - 10.6004/jnccn.2019.0001
M3 - Article
C2 - 30659131
AN - SCOPUS:85060134132
SN - 1540-1405
VL - 17
SP - 64
EP - 84
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 1
ER -